Inovio Accelerates Timeline for COVID-19 DNA Vaccine INO-4800
PLYMOUTH MEETING, Pennsylvania, March 3, 2020 /PRNewswire-AsiaNet/ -- - Human Trials Planned for April; One Million Doses Expected by Year EndInovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced an accelerated timeline for developing its DNA vaccine INO-4800 to address COVID-19, the respiratory infection th...
Authors: LATEST ASIANET NEWS RELEASES